Table: Oncolys Biopharma -2021 parent forecast

Oncolys Biopharma

24/01/2022 06:00

Jan 24 (Reuters) -
              Oncolys Biopharma Inc.     
              PARENT- ONLY EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Dec 31, 2021      Dec 31, 2021   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales           642 mln                       
  Operating      loss 1.42                      
  Recurring      loss 1.47                      
  Net            loss 1.58                      
  EPS         loss 93.57 yen                    
 
  NOTE - Oncolys Biopharma Inc..    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T